Intuitive Surgical, Inc. $ISRG Shares Purchased by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 54,958 shares of the medical equipment provider’s stock after acquiring an additional 1,650 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Intuitive Surgical were worth $24,579,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the stock. SteelPeak Wealth LLC increased its position in shares of Intuitive Surgical by 28.7% during the third quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider’s stock worth $18,781,000 after purchasing an additional 9,364 shares in the last quarter. Amalgamated Bank boosted its stake in Intuitive Surgical by 2.2% during the 2nd quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock worth $44,311,000 after purchasing an additional 1,772 shares during the last quarter. Atlantic Union Bankshares Corp boosted its stake in Intuitive Surgical by 19.3% during the 3rd quarter. Atlantic Union Bankshares Corp now owns 22,759 shares of the medical equipment provider’s stock worth $10,179,000 after purchasing an additional 3,676 shares during the last quarter. Bessemer Group Inc. grew its holdings in shares of Intuitive Surgical by 89.3% during the second quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock worth $428,386,000 after buying an additional 371,806 shares in the last quarter. Finally, World Investment Advisors raised its position in shares of Intuitive Surgical by 238.3% in the third quarter. World Investment Advisors now owns 5,399 shares of the medical equipment provider’s stock valued at $2,415,000 after buying an additional 3,803 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Henry L. Charlton sold 13,731 shares of Intuitive Surgical stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the sale, the executive vice president directly owned 3,056 shares in the company, valued at $1,772,480. This trade represents a 81.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Craig H. Barratt sold 750 shares of the business’s stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $435,000.00. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 70,011 shares of company stock valued at $38,858,275 over the last quarter. 0.70% of the stock is owned by insiders.

Wall Street Analyst Weigh In

ISRG has been the topic of a number of recent research reports. Daiwa Securities Group boosted their price target on shares of Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a research report on Friday, October 24th. Truist Financial raised their target price on shares of Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a research note on Thursday, December 18th. Citigroup restated a “neutral” rating and issued a $590.00 price target (down from $635.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Evercore cut their price target on Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating for the company in a report on Friday, January 23rd. Finally, The Goldman Sachs Group reissued a “buy” rating and set a $714.00 price objective on shares of Intuitive Surgical in a research note on Friday, January 9th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $617.23.

Intuitive Surgical Stock Up 2.5%

NASDAQ:ISRG opened at $488.15 on Monday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $609.08. The stock’s fifty day moving average is $549.63 and its two-hundred day moving average is $510.60. The company has a market capitalization of $173.36 billion, a P/E ratio of 61.87, a P/E/G ratio of 3.79 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The firm had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company’s quarterly revenue was up 18.8% on a year-over-year basis. During the same period last year, the company earned $2.21 EPS. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.